Drug Discovery and the Market Today: Video Exclusive with Dr. David Elder, GSK
06/11/2010
David Elder
| drug discovery
| stability testing
| solubility
| amorphous forms
| genotoxic and carcinogenic impurities
| externalization
|
|
Dr. David Elder, the Externalization Director for GlaxoSmithKline, talks exclusively to Pharma IQ on his perspective across the industry, including CROs, regulations, and strategising for efficiency.
-
BHC- Product Supply: Pipeline Transparency & Risk Asssessment -
Recent Developments in Optimised Forecast Accuracy, Sales and Operations Planning at Merck Serono -
Safety Assessment of Novel Respiratory Delivery Systems: Lessons from the Exubera® Development Program -
Contractor Management -
Cold Chain Management -
Drug Discovery and the Market Today Part 4: Developing Amorphous Forms -
Drug Discovery and the Market Today Part 5: Considering Genotoxic and Carcinogenic Impurities -
Drug Discovery and the Market Today Part 2: Critical Thoughts on Stability -
Drug Discovery and the Market Today Part 3: The Focus on Solubility -
Drug Discovery and the Market Today Part 1: An Overview of Externalisation in the Pharma Industry
You Should Check Out:
* = required.
Not a member yet? Sign up
Events of Interest
-
Improving Solubility
Venue to be confirmed, Munich, Germany
June 26- 28, 2012 -
Global Formulation and Drug Delivery Summit 2012
Park Hotel Amsterdam, Netherlands
April 16- 18, 2012 -
Stability Testing Training Online 2011
August 30, 2011
Register Now -
Predictive Toxicology Summit
Boston, MA
May 21- 23, 2012
You Might Also Like
-
Implementing Thermal Processing Technologies for the Production of Amorphous Solid Dispersions
Amorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid... Read more
Helen Winsor
-
Ensuring Stability the Biggest Amorphous Challenge for 88.2% of Developers
The use of amorphous pharmaceutical materials is widely considered an effective way of improving favourable... Read more
Pharma IQ
-
Using Genotoxicity Tests to Push Drug Development Forward
When it comes to the production of quality drugs and medicines, safety is arguably the fundamental concern... Read more
Pharma IQ
-
Getting to Grips with Stability Testing and Regulatory Compliance
What are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC... Read more
Helen Winsor






Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!